The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

Over 180,000 people are struggling with opioid addiction in Georgia. This number represents ... J.D., M.D., acting director of the FDA’s Center for Drug Evaluation and Research, says the new ...

CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...

Navigating regulatory hurdles in the U.S. and Europe, plus fierce competition from rival Apellis, Astellas’ geographic ...

COLUMBIA, S.C. (WRDW/WAGT) - A new South Carolina bill could change how vapes are sold across the state. This isn’t the first time lawmakers tried to pass a bill like this. In 2023, a similar bill ...

Elsewhere, the Georgia Department of Public Health today reported two more measles cases in unvaccinated Atlanta residents.

Ready-to-eat mini pastries imported from Canada are tied to a new Salmonella Enteritidis outbreak in the United States, ...

Lane Southern Orchards has already adapted to export drops, but operation costs could rise thanks to the tariffs.

The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene Therapeutics’ ALLO-329, an investigational allogenic CAR-T cell therapy. Researchers ...

Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US. The company has received a complete response letter (CRL) from the FDA for a ...